Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

by Ronan W. Hsieh, Steven Borson, Anastasia Tsagianni, Dan P. Zandberg
Published 2021-09-01

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck

by Greg M Delgoffe, Kristin DePeaux, Angen Liu, Dan P Zandberg, Ashley V Menk, Maria Velez, Daniel Normolle
Published 2021-05-01

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

by Andrew G. Sikora, Kevin J. Harrington, R. Bryan Bell, Maura L. Gillison, Quynh-Thu Le, Nancy Y. Lee, Rebecca L. Lewis, Loren K. Mell, Adam Raben, Ravindra Uppaluri, Fernanda Whitworth, Dan P. Zandberg
Published 2019-03-01